2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种

2022-01-05 韩国肠道疾病研究协会 Intest Res

2022年1月,韩国肠道疾病研究协会(KASID)发布了成人炎症性肠病患者SARS-CoV-2接种共识。COVID-19以前所未有的传染性和严重性威胁着全球健康。

中文标题:

2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种

英文标题:

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID

发布日期:

2022-01-05

简要介绍:

2022年1月,韩国肠道疾病研究协会(KASID)发布了成人炎症性肠病患者SARS-CoV-2接种共识。COVID-19以前所未有的传染性和严重性威胁着全球健康。战胜COVID-19的最佳策略是接种疫苗。关于炎症性肠病患者接种疫苗的安全性和有效性的信息仍然不足,本文主要针对成人炎症性肠病患者SARS-CoV-2接种提供共识指导。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b0b1f1c0023112b6, title=2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种, enTitle=SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID, guiderFrom=Intest Res, authorId=0, author=, summary=2022年1月,韩国肠道疾病研究协会(KASID)发布了成人炎症性肠病患者SARS-CoV-2接种共识。COVID-19以前所未有的传染性和严重性威胁着全球健康。, cover=https://img.medsci.cn/202215/1641359773532_1608702.jpg, journalId=0, articlesId=null, associationId=1378, associationName=韩国肠道疾病研究协会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月,韩国肠道疾病研究协会(KASID)发布了成人炎症性肠病患者SARS-CoV-2接种共识。COVID-19以前所未有的传染性和严重性威胁着全球健康。战胜COVID-19的最佳策略是接种疫苗。关于炎症性肠病患者接种疫苗的安全性和有效性的信息仍然不足,本文主要针对成人炎症性肠病患者SARS-CoV-2接种提供共识指导。</span></p>, tagList=[TagDto(tagId=95051, tagName=成人炎症性肠病), TagDto(tagId=112089, tagName=SARS-CoV-2疫苗)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=112089, guiderKeyword=SARS-CoV-2疫苗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5054, appHits=59, showAppHits=0, pcHits=271, showPcHits=4995, likes=0, shares=8, comments=3, approvalStatus=1, publishedTime=Wed Jan 05 13:12:18 CST 2022, publishedTimeString=2022-01-05, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Jan 05 13:16:54 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 11:21:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种.pdf)])
2022 KASID专家共识:成人炎症性肠病患者SARS-CoV-2疫苗接种.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183672, encodeId=aecb11836e275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d8c6462086, createdName=ms5000001639207135, createdTime=Wed Jan 12 21:38:30 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181750, encodeId=678c1181e5092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Jan 07 09:38:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181149, encodeId=a34811811496c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-12 ms5000001639207135

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183672, encodeId=aecb11836e275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d8c6462086, createdName=ms5000001639207135, createdTime=Wed Jan 12 21:38:30 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181750, encodeId=678c1181e5092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Jan 07 09:38:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181149, encodeId=a34811811496c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-07 屋顶瞄爱赏月

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1183672, encodeId=aecb11836e275, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d8c6462086, createdName=ms5000001639207135, createdTime=Wed Jan 12 21:38:30 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181750, encodeId=678c1181e5092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Jan 07 09:38:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181149, encodeId=a34811811496c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-06 微探

    学习学习

    0